ITEMS IN AFP WITH KEYWORD:
Aug 15, 2018 Issue
Identifying Patients with Headache Who Are at Risk of Subarachnoid Hemorrhage [Point-of-Care Guides]
When is urgent imaging warranted in patients presenting with sudden, severe, nontraumatic headache and normal findings on a neurologic examination?
Migraine is a chronic condition characterized by recurrent attacks. Acetaminophen, nonsteroidal anti-inflammatory drugs, triptans, antiemetics, ergot alkaloids, and combination analgesics have evidence supporting their effectiveness. Learn about the three treatment strategies recommended for migraine and when to consider prophylactic therapy.
There is moderate-quality evidence that whole-body acupuncture is effective for migraine prevention. Compared with usual care, acupuncture is more effective at reducing headache frequency by at least 50% (number needed to treat [NNT] = 4).
Topiramate, amitriptyline, and placebo all led to a similar, substantial improvement in migraine frequency and disability. How to harness this strong placebo effect for our patients is an important, but unanswered, question.
Feb 1, 2017 Issue
AAN Updates Guidelines on the Uses of Botulinum Neurotoxin [Practice Guidelines]
In 2008, the American Academy of Neurology (AAN) published guidelines on the use of botulinum neurotoxin. This summary highlights updates on four indications: blepharospasm, cervical dystonia, spasticity in adults, and headache.
Evidence supports current guideline recommendations on the use of valproate medications to prevent migraine.
Studies show an NNT of 3 to have at least a 50% reduction of headache frequency compared with routine care. Want to know more?
May 1, 2016 Issue
Ibuprofen for Treatment of Episodic Tension-Type Headaches [Medicine by the Numbers]
Studies show that 1 in 14 patients were parin-free at two hours and none experienced adverse events. Find out more.
Jul 1, 2014 Issue
Topiramate for the Prophylaxis of Episodic Migraine in Adults [Cochrane for Clinicians]
Topiramate in a dosage of 100 mg per day is effective for decreasing the frequency of headaches in adults with episodic migraine.
May 1, 2014 Issue
Gabapentin for the Prophylaxis of Episodic Migraine in Adults [Cochrane for Clinicians]
Gabapentin does not decrease the frequency of migraine headaches and is not recommended for prophylactic therapy.